What We're Reading: Page 114
Industry reads hand-picked by our editors
Sep 28, 2022
Sep 27, 2022
Sep 26, 2022
Sep 23, 2022
-
The Financial Times
Alzheimer’s drug trial brings pivotal test of maligned brain plaque theory
-
Chemical & Engineering News
Pharma companies race to develop mRNA vaccines for influenza
-
Evaluate Vantage
Novartis has the most new approvals, but Lilly’s are worth more
-
The Wall Street Journal
Moderna Covid-19 Booster Shortage Leads to Fewer Appointments at Pharmacies
Sep 22, 2022
-
Reuters
Novartis to prioritise U.S. market, unfazed by drug pricing pushback
-
The Economist
Fixing the brain
-
Boston Business Journal
Cambridge City Council weighs proposal to ban new labs in Harvard Square, Central Square
-
Washington Post
How to take a pill: Our posture affects how we digest pills, study says
Sep 21, 2022
-
The Wall Street Journal
Asia to Roll Out First Inhaled and Nasal-Spray Covid Vaccines
-
Science
China bets big on brain research with massive cash infusion and openness to monkey studies
-
Boston Business Journal
How a local antibody maker scored its $1.75B deal with Celltrion
Sep 20, 2022
-
STAT
New CRISPR startup seeks to fix diseases caused by large DNA errors
-
Boston Business Journal
Biogen sells one Kendall Square building to Boston Properties, ends lease on another
-
FiercePharma
Manufacturing will be separator for Humira biosim challengers
-
MIT Technology Review
An AI that can design new proteins could help unlock new cures and materials
Previous
